FDA completes re-inspection of Akorn Decatur facility

Globe Newswire
Updated 12/12/2016 8:19 AM

LAKE FOREST -- The U.S. Food and Drug Administration recently conducted a re-inspection of Akorn Inc.'s manufacturing facility in Decatur.

The re-inspection was conducted to verify the implementation and effectiveness of the specialty pharmaceutical company's responses to the observations from the June 2016 FDA inspection.

Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the X in the upper right corner of the comment box. To find our more, read our FAQ.